Ajax-Loading

Astellas Pharma Inc. - Investments

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Investments" stands at -22.16 Billion Japanese Yens for the trailing twelve months (TTM) period ending 12/31/2024, the highest value since 12/31/2022.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 824.20 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 824.20 Billion Japanese Yens.
The 3 year change is 39.59 Billion Japanese Yens.
The 5 year change is 65.52 Billion Japanese Yens.

The Serie's long term average value is -179.84 Billion Japanese Yens. It's latest available value, on 12/31/2024, is 157.68 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 12/31/2023, to it's latest available value, on 12/31/2024, is +824.20 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2017, to it's latest available value, on 12/31/2024, is -40.11 Billion.

Investments for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Investments905,699,262,464.00
LogoJohnson & Johnson - Investments486,508,953,600.00
LogoAbbVie Inc - Investments399,570,305,024.00
LogoRoche Holding AG - Investments317,433,206,677.55
LogoAstraZeneca PLC - Investments280,205,508,085.11